Study: OTOF Gene Therapy Restored Hearing in Deaf Patients
In a new study, gene therapy targeting the OTOF gene significantly restored hearing in children and adults with congenital deafness, with rapid improvement and no serious side effects.
In a new study, gene therapy targeting the OTOF gene significantly restored hearing in children and adults with congenital deafness, with rapid improvement and no serious side effects.
As part of its research and development program, “Horizon 2020,” the European Union (EU) is making 3.8 million euros available for the European School for Interdisciplinary Tinnitus Research (ESIT)—an education program funded by the EU in order to promote tinnitus research in Europe—in order to gather data on a systematic interdisciplinary basis, to research new treatment methods, and to train 15 young scientists for work in the field, ESIT announced.